Tuesday, May 17, 2022
SCIENMAG: Latest Science and Health News
No Result
View All Result
  • Login
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
No Result
View All Result
Scienmag - Latest science news from science magazine
No Result
View All Result
Home SCIENCE NEWS Biology

Newly developed radio-labeled molecule enables real-time imaging of innate immune activity

February 21, 2022
in Biology
0
Share on FacebookShare on Twitter

HOUSTON ― Researchers at The University of Texas MD Anderson Cancer Center have developed a new radio-labeled molecule capable of selectively reacting with certain high-energy radicals that are characteristic of innate immune activity, which may allow a non-invasive approach to monitor inflammation in real time by positron emission tomography (PET) imaging.

David Piwnica-Worms, M.D., Ph.D.

Credit: MD Anderson Cancer Center

HOUSTON ― Researchers at The University of Texas MD Anderson Cancer Center have developed a new radio-labeled molecule capable of selectively reacting with certain high-energy radicals that are characteristic of innate immune activity, which may allow a non-invasive approach to monitor inflammation in real time by positron emission tomography (PET) imaging.

The preclinical study, published today in Nature Biotechnology, takes advantage of new chemistry techniques to synthesize 4-[18F]Fluoro-1-Naphthol ([18F]4FN) as a novel reporter of myeloperoxidase (MPO) activity – a key enzyme active in the innate immune response. The molecule may be able to pinpoint areas of inflammation in a variety of clinical settings, such as inflammatory diseases, infections and immunotherapy-related side effects.

“There has been a long-standing interest in imaging inflammation and redox in general, but most current approaches generate high levels of background noise from biological processes that generate lower-energy radicals,” said corresponding author David Piwnica-Worms, M.D., Ph.D., chair of Cancer Systems Imaging. “Our molecule is tuned toward inflammation mediated by high-energy radicals, offering the potential to selectively monitor activation of innate immunity.” 

The innate immune response is the body’s first line of defense against invading pathogens. In contrast to the adaptive immune response, innate immunity is nonspecific and acts broadly against infections or foreign agents. Innate immunity is largely driven by myeloid cells, including neutrophils, macrophages and natural killer (NK) cells.

Myeloperoxidase is a highly conserved feature of the innate immune response across myeloid cells. This proinflammatory enzyme is activated by hydrogen peroxide to produce a variety of high-energy radicals that are used to eliminate pathogens.

Co-led by Federica Pisaneschi, Ph.D., assistant professor, and Seth T. Gammon, Ph.D., associate professor of Cancer Systems Imaging, the research team focused on MPO activity to develop a redox-tuned reporter specific to innate immune activity. Using newly developed chemistry techniques, the team was able to synthesize [18F]4FN as a labeled molecule to selectively bind nearby proteins and cells when [18F]4FN has been oxidized by MPO plus hydrogen peroxide, but not hydrogen peroxide alone.

The researchers evaluated the potential uses of [18F]4FN as an in vivo PET imaging tool in several laboratory models of inflammation. The molecule was able to successfully highlight inflammation from acute toxic shock, arthritis and contact dermatitis, ailments known to be mediated by activation of innate immunity. In addition, their results suggest [18F]4FN is a more specific and robust reporter of inflammation than other clinically utilized PET imaging agents, such as fluorodeoxyglucose ([18F]FDG).

“We need to verify this PET imaging agent in clinical studies, but it certainly has the potential for broad applications that could benefit patients across all kinds of diseases and clinical scenarios,” Piwnica-Worms said. “A tool like this could be used to identify multi-focal hotspots of inflammation, allowing physicians to intervene before disease progression or to follow the resolution of symptoms during therapy.”

The research team is in discussions with clinical collaborators to test specific applications of [18F]4FN. An initial study, now under Food and Drug Administration review for Investigational New Drug registration and Institutional Review Board approval, will evaluate [18F]4FN as an early biomarker of immune-related adverse events in patients being treated with immune checkpoint inhibitors.

The research was supported by the Gerald Dewey Dodd Jr. Endowed Distinguished Chair, The University of Texas System Faculty STARs Program, and the National Cancer Institute (P30 CA016672).

Additional collaborating authors include Vincenzo Paolillo, Ph.D., and Sarah A. Qureshy, both of Cancer Systems Imaging. Pisaneschi, Gammon and Piwnica-Worms are inventors on a patent application related to the compounds and methods described in this study. The remaining authors have no conflicts of interest.

 

– 30 –



Journal

Nature Biotechnology

DOI

10.1038/s41587-021-01169-y

Method of Research

Experimental study

Subject of Research

Animals

Article Title

Imaging of innate immunity activation in vivo with a redox-tuned PET reporter

Article Publication Date

21-Feb-2022

COI Statement

Pisaneschi, Gammon and Piwnica-Worms are inventors on a patent application related to the compounds and methods described in this study. The remaining authors have no conflicts of interest.

Tags: activitydevelopedenablesimagingimmuneinnatemoleculeNewlyradiolabeledRealtime
Share26Tweet16Share5ShareSendShare
  • Marie Helweg-Larsen, Ph.D.

    New study finds worrying linked to more COVID-19 preventative behaviors

    74 shares
    Share 30 Tweet 19
  • Study provides long-term look at ways to control wildfire in sagebrush steppe ecosystem

    69 shares
    Share 28 Tweet 17
  • Striking new snake species discovered in Paraguay

    68 shares
    Share 27 Tweet 17
  • Extraterrestrial stone brings first supernova clues to Earth

    67 shares
    Share 27 Tweet 17
  • World-first study reveals why people with COPD are more susceptible to COVID-19

    66 shares
    Share 26 Tweet 17
  • Gwangju Institute of Science and Technology researchers develop a tool for studying inflammatory diseases related to COVID-19

    66 shares
    Share 26 Tweet 17
ADVERTISEMENT

About us

We bring you the latest science news from best research centers and universities around the world. Check our website.

Latest NEWS

Understanding how sunscreens damage coral

New Curtin research resurrects ‘lost’ coral species

Huntsman Cancer Institute expands commitment to advance cancer research in the mountain west

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 187 other subscribers

© 2022 Scienmag- Science Magazine: Latest Science News.

No Result
View All Result
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US

© 2022 Scienmag- Science Magazine: Latest Science News.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Posting....